M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy

Chuanfan Zhong, Zining Long, Taowei Yang, Shuo Wang, Weibo Zhong, Feng Hu, Jeremy Yuen‐Chun Teoh, Jianming Lü, Xiangming Mao

International Journal of Biological Sciences · 2023 · 60 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

ratio. Moreover, depletion of circRBM33 significantly increased the response sensitivity to androgen receptor signalling inhibitor (ARSI) therapy, including enzalutamide and darolutamide, in prostate tumours. Our study suggested that the m6A-mediated circRBM33-FMR1 complex can activate mitochondrial metabolism by stabilizing PDHA1 mRNA, which promotes PCa progression, and can attenuate circRBM33 increased ARSI effectiveness in PCa treatment. This newly discovered circRNA may serve as a potential therapeutic target for PCa.

References

38